The natural history of peanut sensitization and allergy in a birth cohort by Arshad, Syed et al.
The Natural History of Peanut Sensitization and Allergy in a Birth 
Cohort
S Hasan Arshad, DM1,2, Carina Venter, PhD1,3, Graham Roberts, DM1,2, Taraneh Dean, 
PhD1,3, and Ramesh Kurukulaaratchy, DM1,2
1
 The David Hide Asthma and Allergy Research Centre, Isle of Wight, UK
2
 Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, UK
3
 School of Health Science and Social Work, University of Portsmouth, UK
Keywords
Peanut Allergy; peanut allergen sensitization; natural history; birth cohort
To the editor,
Information on the natural history of peanut allergic sensitization (PAS) and clinical peanut 
allergy (PA) remains limited. Most previous studies selected children who were diagnosed 
with PA, which does not provide the population perspective and probably ignores those with 
low levels of sensitization.1,2 There are no population based studies on the natural history of 
PAS or PA. To provide a population perspective, we used the Isle of Wight (IoW) birth 
cohort (n=1,456) and determined the natural history of PAS and PA, focusing on incidence, 
persistence and remission. At 1, 2, 4, 10 and 18 years, validated questionnaires were 
completed to obtain information on allergic symptoms, including peanut allergic reactions. 
Skin prick test (SPT) were carried out to 14 aero- and food allergens, including peanut at 
ages 4, 10 and 18 years in all consenting participants and at 1 and 2 years in those with 
allergic symptoms.3 Allergic sensitization was defined as a mean weal diameter of 3 mm 
greater than the negative control to an allergen on SPT. The diagnosis of PA was based on a 
convincing clinical history (one or more recognized allergic symptoms developing within 2 
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hours of food ingestion) plus evidence of sensitization to peanut on SPT. We used the term 
PAS, where SPT was positive to peanut irrespective of clinical reactivity.
Details of experimental methods used and statistical analyses are provided in the online 
supplement of this article. Briefly, prevalence and their 95% confidence intervals were 
calculated. Means of SPT wheal sizes in those with persistent and remittent sensitization 
were compared using T test. Figure E1 (see online repository) provides information on data 
at each assessment. Details of each child sensitized to peanut at age 4, 10 and 18 years is 
provided in table E1, while table E2 provides a complete picture with imputed data (see 
online repository).
PAS increased gradually in the first decade of life but showed a steeper rise from 10 to 18 
years (Fig 1a). At age 4 years, 13 of 976 children (1.3%, 95% confidence intervals (CI): 
0.8%-2.3%) were sensitized to peanut. This increased to 19 of 1034 (1.8%, 95% CI: 
1.2%-2.9%) at age 10 years with a further increase to 54 out of 851 (6.4%, 95% CI: 
4.9-8.2%) at age 18 years. Previous studies have reported a similar prevalence of PAS 
varying from 1.1% to 8.6%.4,5 We show that this is primarily age dependent and varies from 
1.3% in early childhood to 6.8% in adolescence (Fig 1b). At age 1 and 2, only those children 
reporting allergic symptoms were skin prick tested and hence the prevalence could have 
been overestimated. However, prevalence figures at age 1 and 2 are similar to those reported 
previously in another unselected birth cohort on the IoW.6 All peanut sensitized children had 
positive reactions to at least one aeroallergen with grass pollen sensitization being more 
common than tree pollen (Table E3). Cross-reactivity of peanut and grass pollen has been 
reported previously.7 At 4 years, eczema was the major co-morbidity, while at 10 and 18 
years, rhinitis was present in the majority of peanut sensitized children.
The most common pattern of peanut sensitization was its development for the first time at 18 
years; in 42 of 66 children (63.6%, 95% CI: 51.6%-74.2%) in association with grass pollen 
sensitivity and allergic rhinitis (Table 1 & E3). The other common pattern was persistent 
sensitization from age 4 (n=9) or 10 (n=6) years (15 of 66 or 22.7%, 95% CI: 
14.3%-34.2%). However, other patterns where sensitization was transient or recurrent were 
observed in 9 of 66 (13.6%, 95% CI: 73.5%-23.9%) children. The mean difference in wheal 
size of 1.1 mm between persistence (mean; 4.4, SD: 2.0) and transient group (mean; 3.3, SD: 
0.4) failed to reach statistical significance (p=0.06).
There was minimal change in the overall prevalence of PA beyond early childhood and it 
remained around 0.6% (Fig 1b). New onset of PA was uncommon at 10 years (1 of 6) but 
more common at 18 years (3 of 6). Remission of PA was seen in 1 of 6 (17%) between ages 
4 to 10 years and 1 of 4 (25%) from age 10 to 18 years (Table E4). The numbers with PA in 
our study were small and therefore, these findings should be interpreted with caution. 
However, the development of natural tolerance in a small proportion is consistent with 
previous reports.1 We did not observe recurrence of PA, although one patient had recurrence 
of PAS after initial loss of SPT reactivity (Table 1).
The diagnosis of PA can be questioned as oral challenge was not performed. However, a 
history of acute clinical reaction and evidence of allergic sensitization is considered 
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adequate for the diagnosis in most cases.8 Moreover, we have previously shown that even a 
3mm wheal has about 75% positive predictive value for PA if symptoms are present.9 
Another limitation was missing information for SPT, which is inevitable in a long-term 
study, which spans over 20 years.
Sensitization to peanut in early childhood was more commonly associated with clinical 
reactivity than during adolescence. Of those with sensitization at 4 year (n=10), 4 (40%) 
developed PA, while at age 18, only 2 of 42 (4.76%) children with new-onset sensitization 
developed PA (P=0.009). Thus, the increase in the number of subjects sensitized to peanut 
during adolescence was largely due to the onset of asymptomatic sensitization.
In summary, in this cohort, PA started early in childhood and persisted in most children until 
adult life. A few adolescents did have new-onset PA compensating for those who remitted 
and therefore the overall prevalence remained around 0.6%. The natural history of PAS 
differed from that of PA in that it increased gradually from early childhood, with a 
significant peak incidence during adolescence. Most of this new onset sensitization to peanut 
was asymptomatic and associated with pollen sensitization and allergic rhinitis. The 
numbers with peanut allergy were small and thus generalizability of these findings is 
uncertain. Similar assessments in other longitudinally followed birth cohorts will clarify 
developmental patterns of PAS and PA during childhood.
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Capsule summary
In this birth cohort, peanut allergy started in early childhood and persisted until young 
adult life. Allergic sensitization to peanut rose gradually from early childhood, with a 
rapid increase during adolescence; the latter being mostly asymptomatic.
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Figure 1a. Sensitization to peanut on skin prick test from 1 to 18 years of age
Sensitization was defined as a positive SPT to peanut. Numbers above each point represent 
% of participants with sensitization at each assessment point.
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Figure 1b. Clinical allergy to peanut from 1 to 18 years
Clinical allergy to peanut was defined as appearance of typical type I hypersensitivity 
symptoms within 2 hours of exposure to peanut in participants with sensitization on SPT. 
Numbers above each point represent the % of participants with peanut allergy at each 
assessment.
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Table 1
Natural history of sensitization to peanut during childhood.
Sensitized subjects SPT size at 4 year SPT size at 10 year SPT size at 15 year
Pattern of sensitization N=66 Median (IQ range 25-75) Median (IQ range 25-75) Median (IQ range 25-75)
+++ 9 (13.6%) 3.5 (3.0-6.0) 4.5 (3.0-7.5) 5.50 (4.6-9.3)
-++ 6 (9.1%) 0 3.5 (3.0-5.3) 3.50 (3.4-4.3)
--+ 42 (63.6%) 0 0 4.0 (3.3-4.6)
++- 2 (3.0%) 3.3 (3.0-3.5) 4.50 (3.0-6.0) 0
+-- 4 (6.1%) 3.0 (3.0-3.8) 0 0
+-+ 1 (1.5%) 4.0 0 3.8
-+- 2 (3.0%) 0 3.0 (3.0-3.0) 0
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